September 18, 2024 in HighField in the News BioSpace: Data from a Phase 1 Trial of HighField Biopharmaceuticals’ HF1K16 Show the New Immuno-Oncology Drug is Safe and Signals Efficacy in Treating Refractory Metastatic Cancers PJWCreative 0 Like Post 0 Comment Click here Read More
July 17, 2023 in HighField in the News Clinical Trials Arena: HighField Bio initiates its glioma trial with first patient dosing PJWCreative 0 Like Post 0 Comment Click here Read More
July 17, 2023 in HighField in the News Biospace: HighField Biopharmaceuticals Announces First Patient Dosed in Phase 1b/2 Trial of HF1K16 for Recurrent and Refractory Glioma PJWCreative 0 Like Post 0 Comment Click here Read More
June 13, 2023 in HighField in the News Biospace: HighField Biopharmaceuticals Receives US FDA IND Clearance for Phase 1 Trial of Immunoliposome HF158K1 for Treatment of HER2 low and HER2+ Cancers PJWCreative 0 Like Post 0 Comment Click here Read More